VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES
Vertex obtains an exclusive license to TreeFrogs C-StemTM manufacturing technology in type 1 diabetes TreeFrog and Vertex to collaborate on scale-up of fully differentiated, insulin-producing...
United States Morrey Atkinson Rachel Mooney Prnewswire Vertex Pharmaceuticals Incorporated Nasdaq Head Of Biopharmaceutical Sciences Exchange Commission
Source: marketscreener.com